Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Testing of Post-Traumatic Stress Disorder (PTSD) Using the Senseye Diagnostic Tool in Adults : United States, Australia, and Decentralized Trial (DCT) Protocol

NCT07280065 is registered in ClinicalTrials.gov with Senseye, Inc. as lead sponsor.

NCT NCT07280065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07280065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Testing of Post-Traumatic Stress Disorder (PTSD) Using the Senseye Diagnostic Tool in Adults : United States, Australia, and Decentralized Trial (DCT) Protocol
Lead sponsor
Senseye, Inc.
Phase
Phase 3
Overall status
Recruiting
Start date
February 23, 2026
Completion date
October 31, 2026
Enrollment
1,900 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

ptsd - post traumatic stress disorder